BioSpace News Archive

Drug Development

Acorda Snags Approval for New Treatment of OFF Episodes of Parkinson’s Disease

After a delay in review, the FDA approved Acorda’s Inbrija for the intermittent treatment of OFF episodes of Parkinson’s.

December 26, 2018
·
2 min read
·
Alex Keown
Policy

Point-Counterpoint: Senator Warren’s Generic Drug Proposal

In a December 17, Washington Post op-ed, Senator Elizabeth Warren (D-MA), proposed The Affordable Drug Manufacturing Act, which would allow the Department of Health and Human Services (HHS) to manufacture or contract out the manufacture of generic drugs.

December 26, 2018
·
4 min read
·
Mark Terry
Drug Development

SoCal’s Capricor Places Voluntary Hold on DMD Drug Following Allergic Reaction

Capricor Therapeutics has placed a voluntary hold on its Phase II clinical trial for a Duchene Muscular Dystrophy treatment on hold after a patient experienced a severe allergic reaction during dosing.

December 26, 2018
·
3 min read
·
Alex Keown
Pharm Country

7 Biotech Trends to Look Out for in 2019

As 2018 comes to a close, analysts, journalists, investors and industry-watchers are studying their crystal balls to see what trends to watch in the upcoming year. Here are 7 trends most likely to be hitting the news cycle.

December 26, 2018
·
5 min read
·
Mark Terry
Drug Development

With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market

The battle of the bulge is ongoing and it appears that Americans are losing, according to a report from the U.S. Centers for Disease Control and Prevention. The report shows that Americans are losing height and gaining girth.

December 26, 2018
·
4 min read
·
Alex Keown